We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

130 hedge funds and large institutions have $40.7M invested in Sanofi Contingent Value Rights in 2013 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 24 increasing their positions, 32 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less funds holding

Funds holding: 136 → 130 (-6)

16% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 31

25% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 32

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

88% less capital invested

Capital invested by funds: $338M → $40.7M (-$297M)

Holders
130
Holders Change
-6
Holders Change %
-4.41%
% of All Funds
3.77%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.06%
New
26
Increased
24
Reduced
32
Closed
31
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FTCM
Fir Tree Capital Management
New York
+$11.4M
2
CPM
Chesapeake Partners Management
Maryland
+$5.44M
3
MCM
Mason Capital Management
New York
+$4.18M
4
PWAM
Park West Asset Management
California
+$3.63M
5
SI
Standard Investments
New York
+$2.91M

Top Sellers

Rank Fund Capital Flow
1
DI
Dalton Investments
Nevada
-$34M
2
SC
Sculptor Capital
New York
-$24.1M
3
ACM
Abrams Capital Management
Massachusetts
-$23.6M
4
AC
Aristeia Capital
Connecticut
-$13.2M
5
AAA
Alpine Associates Advisors
New Jersey
-$10.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
BMO
26
Beck Mack & Oliver
New York
$185K -$207K -171,600 -24%
ACM
27
Akanthos Capital Management
California
$170K – – –
TL
28
TowerView LLC
New York
$170K +$338K +280,000 +127%
RFC
29
Russell Frank Company
Washington
$168K -$604K -500,000 -56%
DAM
30
Deltec Asset Management
New York
$153K +$472K +390,975 +662%
HA
31
Havens Advisors
New York
$148K -$592K -490,000 -53%
TA
32
Teton Advisors
New York
$136K +$483K +400,000 New
Bank of America
33
Bank of America
North Carolina
$130K -$1.04M -857,024 -69%
CCA
34
Castle Creek Arbitrage
Colorado
$128K +$456K +377,070 New
ACP
35
Andalusian Capital Partners
Connecticut
$122K +$433K +358,575 New
Hudson Bay Capital Management
36
Hudson Bay Capital Management
Connecticut
$112K +$398K +329,400 New
Capstone Investment Advisors
37
Capstone Investment Advisors
New York
$102K -$261K -215,599 -42%
Verition Fund Management
38
Verition Fund Management
Connecticut
$102K +$363K +300,000 New
First Eagle Investment Management
39
First Eagle Investment Management
New York
$78K +$276K +228,000 +16,262%
BCM
40
Basso Capital Management
Connecticut
$75K +$133K +110,000 +100%
JGC
41
J. Goldman & Co
New York
$68K -$72.5K -60,000 -23%
Goldman Sachs
42
Goldman Sachs
New York
$59K +$25.2K +20,818 +14%
YCM
43
Yakira Capital Management
Connecticut
$56K +$199K +164,477 New
FRM
44
Fore Research & Management
New York
$51K +$181K +150,000 New
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
$49K -$89.9K -74,400 -34%
Brown Advisory
46
Brown Advisory
Maryland
$42K +$85.8K +71,000 +137%
U
47
UBS
Switzerland
$36K -$15.3K -12,661 -11%
ZIG
48
Zuckerman Investment Group
Illinois
$36K -$755 -625 -0.6%
PP
49
Paloma Partners
Connecticut
$34K -$453K -375,000 -79%
EEG
50
E.E. Geduld
$34K -$60.4K -50,000 -33%
1
2
3 4 5

GCVRZ Hedge Fund Activity: Q4 2013 in Review

130 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q4 2013, worth a combined $40.7M — down 88% from $338M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of GCVRZ and 26 opened new positions — a net loss of 5 holders — while 32 trimmed existing stakes and 24 added.

The largest buyer was Fir Tree Capital Management, adding an estimated $11.4M. The largest seller was Dalton Investments, exiting entirely with an estimated $34M sold.

  • 130 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q4 2013, down from 136 in Q3 2013.
  • Funds reported $40.7M of Sanofi Contingent Value Rights stock for Q4 2013, down 88% quarter-over-quarter.
  • 26 funds opened new Sanofi Contingent Value Rights positions in Q4 2013 and 31 closed out, a net change of -5 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q4 2013 was Fir Tree Capital Management, an estimated $11.4M added.
  • The largest Sanofi Contingent Value Rights seller in Q4 2013 was Dalton Investments, an estimated $34M sold.

Based on aggregated 13F filings for Q4 2013.